Liu ZB - Search Results

1

[3 cases with idiopathic portal hypertension: a review of literature].

Liu ZB, Lu SC, Li N. Liu ZB, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Aug;19(8):628-9. doi: 10.3760/cma.j.issn.1007-3418.2011.08.019. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152326 Review. Chinese. No abstract available.

2

Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.

Wu M, Liu Z, Zhang A, Li N. Wu M, et al. Medicine (Baltimore). 2019 Feb;98(5):e14287. doi: 10.1097/MD.0000000000014287. Medicine (Baltimore). 2019. PMID: 30702595 Free PMC article.

3

Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.

Wu M, Liu Z, Zhang A, Li N. Wu M, et al. Int J Biol Markers. 2019 Mar;34(1):20-26. doi: 10.1177/1724600818812472. Epub 2019 Mar 10. Int J Biol Markers. 2019. PMID: 30854929 Free article.

4

Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma.

Liu Z, Wu M, Lin D, Li N. Liu Z, et al. J Int Med Res. 2020 Feb;48(2):300060520902575. doi: 10.1177/0300060520902575. J Int Med Res. 2020. PMID: 32054358 Free PMC article.

5

Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.

Wu M, Liu H, Liu Z, Liu C, Zhang A, Li N. Wu M, et al. J Int Med Res. 2018 Oct;46(10):4297-4305. doi: 10.1177/0300060518789304. Epub 2018 Aug 15. J Int Med Res. 2018. PMID: 30111217 Free PMC article.

6

Primary mucosa-associated lymphoid tissue lymphoma of the hilar bile duct resulting in fluctuant jaundice: A case report.

Liu Z, Zang Y, Wang X, Li N, Lin D. Liu Z, et al. Medicine (Baltimore). 2018 Oct;97(41):e12830. doi: 10.1097/MD.0000000000012830. Medicine (Baltimore). 2018. PMID: 30313119 Free PMC article.

7

Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.

Wu M, Liu Z, Li X, Zhang A, Li N. Wu M, et al. Onco Targets Ther. 2020 Jan 28;13:827-840. doi: 10.2147/OTT.S229835. eCollection 2020. Onco Targets Ther. 2020. PMID: 32095079 Free PMC article.

8

Analysis of potential key genes in very early hepatocellular carcinoma.

Wu M, Liu Z, Li X, Zhang A, Lin D, Li N. Wu M, et al. World J Surg Oncol. 2019 May 1;17(1):77. doi: 10.1186/s12957-019-1616-6. World J Surg Oncol. 2019. PMID: 31043166 Free PMC article.

9

NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery.

Xu H, Gu N, Liu ZB, Zheng M, Xiong F, Wang SY, Li N, Lu J. Xu H, et al. Among authors: liu zb. Oncol Lett. 2012 Jan;3(1):39-44. doi: 10.3892/ol.2011.441. Epub 2011 Oct 13. Oncol Lett. 2012. PMID: 22740853 Free PMC article.

10

Downstaging of Recurrent Advanced Hepatocellular Carcinoma After Lenvatinib Treatment: Opportunities or Pitfalls? A Case Report.

Liu Z, Fu Z, Li G, Lin D. Liu Z, et al. Onco Targets Ther. 2020 Oct 13;13:10267-10273. doi: 10.2147/OTT.S261521. eCollection 2020. Onco Targets Ther. 2020. PMID: 33116607 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

396 results

Search Page

Filters